Study of the Week: Study Reveals a Key Mechanism of Neurodegenerative Diseases
source: pixabay.com

Study of the Week: Study Reveals a Key Mechanism of Neurodegenerative Diseases

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Study Reveals a Key Mechanism of Neurodegenerative Diseases

Nucala is Now Approved For 4 Rare Eosinophil-Based Diseases in Europe

GlaxoSmithKline has recently announced their new approval of Nucala by the European Commission. This therapy has been approved for three new diseases, all of which are driven by eosinophils. Nucala is…

Continue Reading Nucala is Now Approved For 4 Rare Eosinophil-Based Diseases in Europe

The Fight For Access For Alpha-1 Antitrypsin Deficiency Treatment Across Canada

November was alpha-1 antitrypsin deficiency (A1AD) awareness month, and A1AD is certainly a rare disease which deserves more awareness. Even with universal healthcare in Canada, many patients who have alpha-1 antitrypsin deficiency…

Continue Reading The Fight For Access For Alpha-1 Antitrypsin Deficiency Treatment Across Canada
FDA Accepts NDA For Parsaclisib for Non-Hodgkin Lymphoma
source: pixabay.com

FDA Accepts NDA For Parsaclisib for Non-Hodgkin Lymphoma

The FDA will review parsaclisib as a treatment for Non-Hodgkin lymphoma (NHL) after accepting Incyte's New Drug Application (NDA). Specifically, the NDA was submitted for the treatment of relapsed or…

Continue Reading FDA Accepts NDA For Parsaclisib for Non-Hodgkin Lymphoma

New Treatment Found To Reduce Hyperkalemia Risk in Those With CKD and Type 2 Diabetes

A recent clinical trial called CREDENCE has uncovered that canagliflozin, a sodium-glucose cotransporter 2 (SGLT2), can reduce hyperkalemia risk in chronic kidney disease (CKD) and type 2 diabetes patients who…

Continue Reading New Treatment Found To Reduce Hyperkalemia Risk in Those With CKD and Type 2 Diabetes
Insulin/Dextrose as Management for Hyperkalemia Only Transiently Effective
Pixabay: https://pixabay.com/en/medic-hospital-laboratory-medical-563425/

Insulin/Dextrose as Management for Hyperkalemia Only Transiently Effective

According to a recent article, a recent study from the U.K. showed that emergency methods of managing hyperkalemia, such as the use of insulin/dextrose, are not the most effective treatments.…

Continue Reading Insulin/Dextrose as Management for Hyperkalemia Only Transiently Effective